Cardinal Health (CAH)
(Real Time Quote from BATS)
$112.34 USD
+0.58 (0.52%)
Updated Oct 8, 2024 02:36 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Income Statements
Fiscal Year end for Cardinal Health, Inc falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 226,827 | 205,012 | 181,364 | 162,467 | 152,922 |
Cost Of Goods | 219,413 | 198,123 | 174,819 | 155,689 | 146,054 |
Gross Profit | 7,414 | 6,889 | 6,545 | 6,778 | 6,868 |
Selling & Adminstrative & Depr. & Amort Expenses | 6,171 | 6,162 | 7,141 | 6,306 | 10,966 |
Income After Depreciation & Amortization | 1,243 | 727 | -596 | 472 | -4,098 |
Non-Operating Income | 9 | 4 | -24 | 31 | 564 |
Interest Expense | 51 | 93 | 149 | 180 | 238 |
Pretax Income | 1,201 | 638 | -769 | 323 | -3,772 |
Income Taxes | 348 | 376 | 163 | -289 | -79 |
Minority Interest | 1 | 1 | 1 | 1 | 3 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 853 | 262 | -932 | 612 | -3,693 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 852 | 261 | -933 | 611 | -3,696 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,953 | 1,419 | 96 | 1,255 | -3,185 |
Depreciation & Amortization (Cash Flow) | 710 | 692 | 692 | 783 | 913 |
Income After Depreciation & Amortization | 1,243 | 727 | -596 | 472 | -4,098 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 247.00 | 262.00 | 279.00 | 294.00 | 293.00 |
Diluted EPS Before Non-Recurring Items | 7.53 | 5.79 | 5.06 | 5.57 | 5.45 |
Diluted Net EPS (GAAP) | 3.45 | 1.00 | -3.35 | 2.08 | -12.61 |
Fiscal Year end for Cardinal Health, Inc falls in the month of June .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | NA | 59,708.00 | 54,911.00 | 57,445.00 | 54,763.00 |
Cost Of Goods | NA | 57,855.00 | 52,964.00 | 55,599.00 | 52,995.00 |
Gross Profit | NA | 1,853.00 | 1,947.00 | 1,846.00 | 1,768.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,445.00 | 1,580.00 | 1,364.00 | 1,782.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 408.00 | 367.00 | 482.00 | -14.00 |
Non-Operating Income | NA | -16.00 | 7.00 | 16.00 | 2.00 |
Interest Expense | NA | -4.00 | 33.00 | 8.00 | 14.00 |
Pretax Income | NA | 396.00 | 341.00 | 490.00 | -26.00 |
Income Taxes | NA | 162.00 | 82.00 | 136.00 | -32.00 |
Minority Interest | NA | -2.00 | 1.00 | 1.00 | 1.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 234.00 | 259.00 | 354.00 | 6.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 236.00 | 258.00 | 353.00 | 5.00 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 244.00 | 245.00 | 246.00 | 250.00 |
Diluted EPS Before Non-Recurring Items | NA | 1.84 | 2.08 | 1.82 | 1.73 |
Diluted Net EPS (GAAP) | NA | 0.95 | 1.05 | 1.43 | 0.02 |